Form 4 for TDOC Teladoc Health, Inc.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-19 · accession 0001628280-25-042320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-22 | 2025-09-19 | TDOC | Evans Jason Eric | Dir | M - OptEx | — | +1,016 | 8,129 | +14% | — |
| D | 2025-09-22 | 2025-09-19 | TDOC | Evans Jason Eric | Dir | M - OptEx | $0.00 | -1,016 | 4,066 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-19 | M | A | 1,016 | — | 8,129 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2025-09-19 | M | D | 1,016 | $0.00 | 4,066 | D | — · — to — | 1,016 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F2) On September 20, 2023, the reporting person was granted 12,195 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |